verapamil has been researched along with Gingival Overgrowth in 5 studies
Verapamil: A calcium channel blocker that is a class IV anti-arrhythmia agent.
verapamil : A racemate comprising equimolar amounts of dexverapamil and (S)-verapamil. An L-type calcium channel blocker of the phenylalkylamine class, it is used (particularly as the hydrochloride salt) in the treatment of hypertension, angina pectoris and cardiac arrhythmia, and as a preventive medication for migraine.
2-(3,4-dimethoxyphenyl)-5-{[2-(3,4-dimethoxyphenyl)ethyl](methyl)amino}-2-(propan-2-yl)pentanenitrile : A tertiary amino compound that is 3,4-dimethoxyphenylethylamine in which the hydrogens attached to the nitrogen are replaced by a methyl group and a 4-cyano-4-(3,4-dimethoxyphenyl)-5-methylhexyl group.
Gingival Overgrowth: Excessive growth of the gingiva either by an increase in the size of the constituent cells (GINGIVAL HYPERTROPHY) or by an increase in their number (GINGIVAL HYPERPLASIA). (From Jablonski's Dictionary of Dentistry, 1992, p574)
| Excerpt | Relevance | Reference |
|---|---|---|
| "Patients taking diltiazem are at high risk for gingival enlargement and gingivitis has a stronger effect than the drug treatment on gingival enlargement risk." | 7.73 | Prevalence and risk of gingival overgrowth in patients treated with diltiazem or verapamil. ( Berini, L; Brunet, L; Farré, M; Mendieta, C; Miranda, J; Roset, P, 2005) |
| "This study has been designed to investigate the immunogenetic susceptibility of Cyclosporine-A (CsA) immunosuppressed renal transplant patients to development of gingival overgrowth, and the amplifying effect of calcium channel blockers on the severity of this clinical entity." | 7.69 | Evaluation of the frequency of HLA determinants in patients with gingival overgrowth induced by cyclosporine-A. ( Aydin, AE; Aygün, S; Carin, M; Cebeci, I; Firatli, E; Güç, U; Kantarci, A; Tanyeri, H; Tuncer, O, 1996) |
| "Patients taking diltiazem are at high risk for gingival enlargement and gingivitis has a stronger effect than the drug treatment on gingival enlargement risk." | 3.73 | Prevalence and risk of gingival overgrowth in patients treated with diltiazem or verapamil. ( Berini, L; Brunet, L; Farré, M; Mendieta, C; Miranda, J; Roset, P, 2005) |
| "This study has been designed to investigate the immunogenetic susceptibility of Cyclosporine-A (CsA) immunosuppressed renal transplant patients to development of gingival overgrowth, and the amplifying effect of calcium channel blockers on the severity of this clinical entity." | 3.69 | Evaluation of the frequency of HLA determinants in patients with gingival overgrowth induced by cyclosporine-A. ( Aydin, AE; Aygün, S; Carin, M; Cebeci, I; Firatli, E; Güç, U; Kantarci, A; Tanyeri, H; Tuncer, O, 1996) |
| "Verapamil is an effective prophylactic treatment for cluster headaches and, therefore, is widely used." | 1.33 | Verapamil induced gingival enlargement in cluster headache. ( Ferrari, MD; Goadsby, PJ; Matharu, MS; van Vliet, JA, 2005) |
| "Phenytoin was used as a positive control." | 1.31 | Comparative study of calcium-channel blockers on cell proliferation, DNA and collagen syntheses, and EGF receptors of cultured gingival fibroblasts derived from human nifedipine, nicardipine and nisoldipine responders. ( Akimoto, Y; Fujii, A; Matsumoto, H; Noji, I, 2001) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (40.00) | 18.2507 |
| 2000's | 3 (60.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Matharu, MS | 1 |
| van Vliet, JA | 1 |
| Ferrari, MD | 1 |
| Goadsby, PJ | 1 |
| Miranda, J | 1 |
| Brunet, L | 1 |
| Roset, P | 1 |
| Berini, L | 1 |
| Farré, M | 1 |
| Mendieta, C | 1 |
| Cebeci, I | 1 |
| Kantarci, A | 1 |
| Firatli, E | 1 |
| Aygün, S | 1 |
| Tanyeri, H | 1 |
| Aydin, AE | 1 |
| Carin, M | 1 |
| Güç, U | 1 |
| Tuncer, O | 1 |
| Desai, P | 1 |
| Silver, JG | 1 |
| Matsumoto, H | 1 |
| Noji, I | 1 |
| Akimoto, Y | 1 |
| Fujii, A | 1 |
1 review available for verapamil and Gingival Overgrowth
| Article | Year |
|---|---|
Drug-induced gingival enlargements.
Topics: Anticonvulsants; Calcium Channel Blockers; Cyclosporine; Gingival Overgrowth; Humans; Immunosuppress | 1998 |
4 other studies available for verapamil and Gingival Overgrowth
| Article | Year |
|---|---|
Verapamil induced gingival enlargement in cluster headache.
Topics: Adult; Calcium Channel Blockers; Cluster Headache; Female; Gingival Overgrowth; Humans; Male; Verapa | 2005 |
Prevalence and risk of gingival overgrowth in patients treated with diltiazem or verapamil.
Topics: Aged; Aged, 80 and over; Calcium Channel Blockers; Cross-Sectional Studies; Dental Plaque Index; Dil | 2005 |
Evaluation of the frequency of HLA determinants in patients with gingival overgrowth induced by cyclosporine-A.
Topics: Adult; Antigenic Variation; Calcium Channel Blockers; Chi-Square Distribution; Cyclosporine; Diltiaz | 1996 |
Comparative study of calcium-channel blockers on cell proliferation, DNA and collagen syntheses, and EGF receptors of cultured gingival fibroblasts derived from human nifedipine, nicardipine and nisoldipine responders.
Topics: Adult; Aged; Analysis of Variance; Anticonvulsants; Calcium Channel Blockers; Cell Culture Technique | 2001 |